Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO)

David Pasquier (1, 2) , Philippe Nickers , Didier Peiffert (3) , Philippe Maingon (4) , Pascal Pommier (5) , Thomas Lacornerie (6) , Geoffrey Martinage , Emmanuelle Tresch , Eric Lartigau (6) , Amir Abdollahi

1 Service de radiothérapie / curiethérapie
2 CRIStAL - Centre de Recherche en Informatique, Signal et Automatique de Lille - UMR 9189
3 UNICANCER/ICL - Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy]
4 UNICANCER/CRLCC-CGFL - Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon]
5 Centre Léon Bérard [Lyon]
6 UNICANCER/Lille - Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille]

Domaines: Sciences du Vivant [q-bio]; Cancer

David Pasquier, Philippe Nickers, Didier Peiffert, Philippe Maingon, Pascal Pommier, et al.. Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO). PLoS ONE, 2017, 12 (11), pp.e0187794. ⟨hal-02021721⟩